News & Events
News
BioBridge Symposium held at 30th World Congress of the International Society of Lymphology (ISL)
Fibralign Corp. and leading physicians presented an update on clinical findings and case studies during the 30th World Congress of the International Society of Lymphology (ISL), which was held 15-19 October 2025 in Antalya, Turkey. As part of this session, Dr. Corrado...
Good Moonwha Hospital completes 100th BioBridge surgical case milestone.
Fibralign Corp. and its South Korean distributor Healing Solutions, LTD announced today that Good Moonwha Hospital completed its 100th BioBridge case in the surgical treatment of lymphedema. Good Moonhwa is the first medical center in Asia and second worldwide to...
Japan BioBridge PMDA Study Completion
Terumo Corporation announced that the first clinical trial conducted in Japan for evaluation the BioBridge® Collagen Matrix in the surgical treatment of lymphedema has reached its endpoint. Terumo is managing and funding clinical studies in Japan which are being used...
Conferences
Fibralign and its research collaborators have made over 50 presentations related to BioBridge and Nanoweave scientific findings at international leading medical research conferences over the previous two years.
While these conferences have largely paused during 2020 due to the pandemic, we will post upcoming presentations when these conferences return to schedule.
